Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Comment by Cryptobreakon Mar 18, 2020 4:27pm
60 Views
Post# 30823395

RE:RE:Press Release this a.m.

RE:RE:Press Release this a.m."why in the hell would a basher release a pumped up fake ?" To accuse people of pumping... Ceo's don't post on stockhouse, especially at a busy time like now. Whoever, purposely posted that the account had been open long ago while it was obviously newly created in order to discredit it...
PowerofNow wrote: Is it ironic that the day after CEO, David Goren posted here a news release comes out? Someone said a basher made up account why in the hell would a basher release a pumped up fake ? Could b lejat
DavidGoren wrote: Been noticing tremendous, passionate efforts from investors on various social media platforms in relation to sharing Our Company's mission of getting the Covid-19 Vaccine to world. I personally assure you that we are moving at rocket speeds towards attaining this goal; 24/7 our team is working diligently to get this approved & released. As some of you reading this may wonder we will receive the vaccine & then start conducting trials on the infected in a few weeks time. Following this, getting it approved for the public domain will be a lengthy process, but hopefully no longer than 6 months. Stay safe everyone & take care. P.S -- Made this account years ago to secure name but never use it. This will be my first & only post. Do not expect me to come back with anything else to say. Just remember that we are on the World Health Organizations vaccine candidate list, even if we don't win 1st place in the race for the vaccine at 2nd, 3rd or 4th; it still puts us all in a very hefty position.

https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1


calico wrote:

VAXIL CHANGES WEBSITE DOMAIN NAME, PROVIDES UPDATE ON THE EXERCISE OF WARRANTS AND RECEIVES FINAL TSXV EXCHANGE APPROVAL ON THE DEBENTURE FINANCINGS

 

 




Bullboard Posts